How Vitamin D Boosts the Body's Natural Antiviral Peptides

This is a book chapter reviewing the current evidence on vitamin D's immunomodulatory effects, focusing specifically on its role in inducing antimicrobial peptide production and the antiviral functions of these peptides. The review synthesizes research from in vitro studies, in vivo models, and clinical observations.

Drug-resistant infections are a global health emergency, and new antiviral approaches are urgently needed. Antimicrobial peptides represent the body's first line of defense — millions of years of evolution have optimized them against pathogens. Understanding how vitamin D regulates these peptides could lead to simple, accessible interventions (vitamin D supplementation) that boost natural antiviral immunity, particularly in populations with widespread vitamin D deficiency.

The connection between vitamin D and antimicrobial peptides (particularly cathelicidin/LL-37 and defensins) has been one of the most impactful discoveries in nutritional immunology. This work has implications for understanding why vitamin D deficiency is associated with increased susceptibility to respiratory infections, why winter (when vitamin D levels drop) corresponds to flu season, and why certain populations with low vitamin D status have worse outcomes from viral infections including COVID-19. The AMP pathway provides a mechanistic explanation for vitamin D's immune benefits.

As a review chapter, this does not present original experimental data. The evidence linking vitamin D supplementation to clinically meaningful reductions in viral infections is mixed, with some large clinical trials showing modest benefits and others showing none. The abstract does not discuss specific AMPs (like cathelicidin or defensins) or the optimal vitamin D levels needed for AMP induction. Most mechanistic evidence comes from in vitro studies, and translating AMP induction into clinical protection against viral disease has proven challenging.